'Sell the Trump Presser' Can't Hold; Dow 20K on Thursday?

 | Jan 11, 2017 | 4:30 PM EST
  • Comment
  • Print Print
  • Print

The "sell the Trump press conference" trade worked for about two hours but it was probably too crowded. It was an obvious setup and when that is the case there are always dip buyers lurking. In fact, it is very likely that there are algorithms now in place to buy the Trump-created dips.

There certainly isn't any sustained momentum when the market reacts to a negative Trump comment. Once the indices started to bounce it helped to create a squeeze into the close and a very strong finish.

The biotechnology sector suffered some damage, which is a bit worrisome, but by the end of the day breadth was solidly positive again and the indices back to the highs of the day. The Trump press conference only created a little intraday volatility.

While it was a solid recovery for the indices, the issue lately is it's becoming increasingly difficult for the market to gain upside traction. Leadership is poor, with few clear themes, although it keeps the indices up. There are setups to be found but it is a constant debate over whether to take a trade you don't like that much. As a result it is very challenging to put cash to work.

With the strong close today it is very likely we are going to hear about Dow 20,000 again Thursday. The DJIA is only about 50 points away again and the fourth or fifth time may be the charm. The conventional wisdom is that the market can't undergo a substantial correction until that level is taken out first so we shall see.

Although the indices are holding well and give the market an appearance of complacency, it has been a tough market to trade lately. The rotation, lack of leadership and the swings on Trump make it hard to catch sustained moves. At this juncture, it appears the bears might end up being squeezed once again.

Have a good evening. I'll see you tomorrow.

Columnist Conversations

I reached out last week to my close friend Ken Shreve, who is a prominent writer for the IBD.  I asked Ke...
I reached out last week to my close friend Ken Shreve, who is a prominent writer for the IBD.  I asked Ke...
View Chart »  View in New Window »
we will add this here to cheaply protect our downside a bit BOUGHT SPY SEP 244 PUT AT 2.70 ...



News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.